EN
CN
EN
About us
About Accropeutics
Core Team
SAB
Milestone
Investors
Focus Areas
R&D
Publications
Pipeline
Partnerships
News
Join Us
Our Culture
Job Opportunities
Contact Us
About us
Back
About Accropeutics
Core Team
SAB
Milestone
Investors
Focus Areas
Back
R&D
Publications
Pipeline
Partnerships
News
Join Us
Back
Our Culture
Job Opportunities
Contact Us
Home
/
Focus Areas
/
Publications
Publications
Innovative pharmaceutical high-tech company
Scroll Down
August. 01, 2023
Discovery of a novel RIPK2 inhibitor for the treatment of inflammatory bowel disease
Learn More
March. 02, 2023
A novel RIPK1 inhibitor reduces GVHD in mice via a nonimmunosuppressive mechanism that restores intestinal homeostasis
Learn More
May. 05, 2021
Ring closure strategy leads to potent RIPK3 inhibitors
Learn More
December. 08, 2020
Discovery of a Potent RIPK3 Inhibitor for the Amelioration of Necroptosis-Associated Inflammatory Injury
Learn More
June. 24, 2019
Discovery of potent necroptosis inhibitors targeting RIPK1 kinase activity for the treatment of inflammatory disorder and cancer metastasis
Learn More
